Vikas A. Gupta

The Nf2 Tumor Suppressor, Merlin, Functions in Rac-Dependent Signaling

Reuben J. Shaw, J. Guillermo Paez, Marcello Curto et al. · Developmental Cell · 2001 · 342 citations · Full text

Signaling Pathway, Medicine, Nf2 Tumor Suppressor +5

Long-Term Follow-Up Results of Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy and Risk-Adapted Maintenance Approach in Newly Diagnosed Multiple Myeloma

Nisha S. Joseph, Jonathan L. Kaufman, Madhav V. Dhodapkar et al. · Journal of Clinical Oncology · 2020 · 231 citations · Full text

Gain of Chromosome 1q is associated with early progression in multiple myeloma patients treated with lenalidomide, bortezomib, and dexamethasone

Timothy M. Schmidt, Benjamin G. Barwick, Nisha S. Joseph et al. · Blood Cancer Journal · 2019 · 163 citations · Full text

Multiple myeloma immunoglobulin lambda translocations portend poor prognosis

Benjamin G. Barwick, Paola Neri, Nizar J. Bahlis et al. · Nature Communications · 2019 · 153 citations · Full text

Dexamethasone treatment promotes Bcl-2 dependence in multiple myeloma resulting in sensitivity to venetoclax

Shannon M. Matulis, Vikas A. Gupta, A K Nooka et al. · Leukemia · 2015 · 132 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Autoimmune Disease +8